Consio | $3,300,000 | (Jan 27, 2026)
Orbital(US) | $60,000,000 | (Jan 27, 2026)
Inferact | $150,000,000 | (Jan 27, 2026)
Certified by Founder
Lodge
SOLASTA Bio
start up
United Kingdom
- Glasgow
- 12/04/2023
- Pre Series A
- $4,967,000
SOLASTA Bio is an ambitious bioinsecticides start up with a unique proposition: nature-inspired small molecule insect control products for the global agricultural market. We are a small but passionate and world-leading team - join us!
- Industry Biotechnology Research
- Website N/A
- LinkedIn https://www.linkedin.com/company/solasta-bio/
Related People
Shireen DaviesFounder
United Kingdom -
East Dunbartonshire, Scotland
Founder CEO of SOLASTA Bio, developing innovative peptide insecticides for global agriculture.
A recent UKRI BBSRC Royal Society of Edinburgh Enterprise Fellow with a leading track record in technology innovation and fundraising.
Visitt | $22,000,000 | (Jan 27, 2026)
Cashmere(US) | $5,000,000 | (Jan 27, 2026)
Barnwell Bio | $6,000,000 | (Jan 27, 2026)
Mine(US) | $14,000,000 | (Jan 27, 2026)
Lucend | $3,300,000 | (Jan 27, 2026)
Standard Nuclear | $140,000,000 | (Jan 27, 2026)
Yuki | $6,000,000 | (Jan 23, 2026)
Allocation Strategy | $2,164,392 | (Jan 23, 2026)
Mia Labs | $20,000,000 | (Jan 23, 2026)